2-(4-Bromophenyl)-4-chloro-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine

Catalog No. :
ACOMID634
CAS No. :
1956326-67-2
Molecular Formula :
C13H10BrClN2O
Molecular Weight :
325.59

IUPAC Name:2-(4-bromophenyl)-4-chloro-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine

2-(4-Bromophenyl)-4-chloro-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1295.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Bromophenyl)-4-chloro-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine
IUPAC Name2-(4-bromophenyl)-4-chloro-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine
MDL No.MFCD27991621
Molecular FormulaC13H10BrClN2O
Molecular Weight325.59
SMILESClC1=C(COCC2)C2=NC(C3=CC=C(Br)C=C3)=N1
InChI KeyOFWUFUVLCZNQIR-UHFFFAOYSA-N
Synonym2-(4-BROMOPHENYL)-4-CHLORO-7,8-DIHYDRO-5H-PYRANO[4,3-D]PYRIMIDINE;5H-Pyrano[4,3-d]pyrimidine, 2-(4-bromophenyl)-4-chloro-7,8-dihydro-
CAS No.1956326-67-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOMID634 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACORZA378 route compound structure diagram
    ACORZA378944902-88-9 In Stock
  2. Plus
  3. ACEGJX062 route compound structure diagram
    ACEGJX0625467-74-3 In Stock
  4. Then
  5. ACOMID634 route product structure diagram
    ACOMID6341956326-67-2
Inquiry

2. ACOMID634 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHPYN347 route compound structure diagram
    ACHPYN34768716-49-4 In Stock
  2. Plus
  3. ACORZA378 route compound structure diagram
    ACORZA378944902-88-9 In Stock
  4. Then
  5. ACOMID634 route product structure diagram
    ACOMID6341956326-67-2
Inquiry

Comments (0)